|
⚲
|
| Keyboard |
| Viridian PE Management LLC
✚
|
|
|---|---|
| CRD # | 337301 |
| SEC # | 801-134278 |
| CIK # | |
| AUM | 33.2 M (2026-03-25) |
| Employees | 6 (83% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 914-589-5969 |
| Address | 2900 Westchester Ave Purchase, NY 10577 |
| Source | [IAPD] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/25/2026) [Brochure] |
|---|
Item 5 – Fees and Compensation The Fund will generally pay the Firm for its investment advisory services (“Management Fees”). Management Fees are charged as a percentage of committed capital during the commitment period and on outstanding capital contributions thereafter. Annualized Management Fees rates are disclosed in each Fund’s offering documents and generally are up to 2%, charged directly to a Fund, quarterly in arrears. In addition, the Firm’s affiliate, the General Partner, will receive incentive compensation from the Fund for acting in that capacity, as discussed in Item 6, below. In addition to paying management and performance fees, the Funds also pay other investment expenses including, but not limited to, registration and custodial fees, commissions and related costs, interest costs, insurance costs, indemnification and litigation costs, taxes, duties and other governmental charges, legal fees, administrator fees, internal and external accounting fees, audit and tax preparation fees, and transaction and due diligence expenses (whether or not the transaction or investment is consummated). Investors will be allocated their pro rata share of such additional fees and expenses. Investors who invest in the Fund at a later stage will bear their proportionate share of such fees and expenses as if they had been initial investors in the Fund. Such expenses are disclosed more fully in each Fund’s governing documents. |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/25/2026) [Brochure] |
|---|
Item 7 – Types of Clients
We provide investment advice to the Funds. Interests in the Funds are offered pursuant to
applicable exemptions from registration under the Securities Act of 1933 (“Securities Act”) and
the Investment Company Act of 1940 (“1940 Act”). Investors in the Funds are generally “qualified
purchasers” as defined in the 1940 Act and include mostly high-net-worth individuals.
The minimum commitment by each Fund investor is $5 million, unless waived or reduced by the
General Partner in its sole discretion.
Item 8 – Method of Analysis, Investment Strategies and Risk of Loss
Investment Strategies and Methods of Analysis
The Fund offers investors the opportunity to invest in portfolio companies and greenfield
investments that Viridian believes have upside potential via equity, and equity-like investments,
on a global basis.
The Fund expects to pursue an investment strategy in the following sectors:
Cleantech and Environmental Remediation Businesses
Following the launch of the Fund, Viridian intends to immediately seek to acquire global licenses
for waste remediation technologies that produce high value output products with established
off-take markets. These waste remediation technologies will each have multiple applications,
and will be fully developed technologies, for which the cost of acquisition or control equity
investment is prohibitively high, but for which licensing and rights to operate are available and fit
within the Fund investment mandate and financial objectives.
Defense Businesses
The Fund intends to enter into joint ventures, utilizing Fund equity control positions, with global
leading subject matter experts in the defense sector to address the key force readiness and new
technological innovation priorities of the United States Department of Defense, for U.S.
domestic production of critical path requirements. The Fund will operate the businesses housed
in these joint ventures when necessary and/or provide “capital plus” support when the joint
venture partner has sufficient operating expertise and market and sales access. The Fund will
seek opportunities to further leverage these activities in support of U.S. domestic aviation and
other infrastructure classes. In select cases, based on Viridian’s Investment Committee
process, non-joint venture, non-control equity investments will be considered with qualified
portfolio companies in support of these objectives.
Advanced and Applied Materials Production Technology Businesses
The Fund also intends to enter into joint ventures, license, directly acquire, or make equity
control investments in proven advanced and applied material production technologies and
systems. The two-fold purpose of these investments are:
1) to reduce the cost and accelerate the rapid market adoption of graphene and other
advanced materials, such that the U.S. and other developed economies can reduce
their reliance on rare earth metals and minerals from strategic competitors. A primary
objective of the investment in these production technologies and systems is to
immediately leverage successful low-cost graphene production into well-developed
follow-on technologies such as advanced battery chemistries and technologies,
supporting accelerated electrification of the economy through mass energy storage,
and high-quality, commercially applicable safer battery systems; and
2) to reduce the cost and accelerate the rapid market adoption of ultra-high-
performance concrete (“UHPC”) and other innovative applied materials, such that
scaling the design and construction of highly durable climate resilient infrastructure
projects and affordable low-cost housing becomes a feasible reality. Viridian believes
that such technology may also be used to produce UHPC railroad ties as
replacements for wood ties.
Viridian anticipates that the Fund’s investments in these activities will be a meaningful
percentage of the overall invested capital of the Fund.
Healthcare Technology Assets
Viridian, on behalf of the Fund, intends to access its network of subject matter experts,
researchers, clinicians and diagnosticians in the fields of geroprotective science,
neurodegenerative disease mitigation (neuroprotective), and critical organ health and
restoration to identify novel therapies, protocols, and scalable applications we believe to be
market-ready that will include diagnostics and delivery technologies. The Fund will seek to invest
primarily in equity control positions in these technologies. Viridian expects that investments in
this sector will comprise a smaller percentage of the Fund investments.
In evaluating investments for consideration for inclusion in the Fund, Viridian assesses the
following primary factors:
• Does the opportunity address a significant, broad-based challenge for society?
Specifically, is this an opportunity that has the potential for a meaningful and
durable impact if solved?
• Is the opportunity scalable? Can an investment be scaled either by the number
and size of investments, geography and/or into adjacent applications?
• Does the opportunity integrate, or leverage, technology? Viridian will assess
whether an investment utilizes proven technologies in new, or novel, ways and in
a manner that produces an underlying technological base for the investment. In
addition, does the technology provide barriers to competition?
• Does the opportunity provide attractive investment returns to the Fund? Viridian
expects to prioritize investments that are expected to produce measurable free
cash flow to the Fund within a defined period of time.
• Are there a range of potential exit strategies? As appropriate, and consistent with
... |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Viridian Capital Investment Fund I LP | 2025-08-01 | 33.2 M |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 1 | 33.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 1 | 33.2 |
| By Discretionary | ||
| Discretionary | 1 | 33.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 1 | 33.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 33.2 | |
| Total | 1 | 33.2 |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
Nordwand Investments LLC
✚
|
PA | 44.7 M |
|
ACME Credit Partners LLC
✚
|
NY | 43.8 M |
|
HKW Management LLC
✚
|
42.5 M | |
|
Tabernacle Equity Management LLC
✚
|
TX | 41.5 M |
|
Palladium Heritage Management LLC
✚
|
NY | 37.2 M |
|
Stockwell Ventures LLC
✚
|
NY | 30.0 M |
|
Xcellerant Ventures LLC
✚
|
AZ | 26.0 M |
|
Map Funds Management LLC
✚
|
MA | 25.8 M |
|
Stonetree Capital Advisors LLC
✚
|
22.0 M | |
|
RCP Advisors LLC
✚
|
IL | 21.0 M |